3 More FTSE 100 Shares With Fast-Improving Forecasts: GlaxoSmithKline plc, Smiths Group plc And Schroders plc

GlaxoSmithKline plc (LON:GSK), Smiths Group plc (LON:SMIN) and Schroders plc (LON:SDR) have all received forecast upgrades recently. What is the outlook for the shares?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

GlaxoSmithKline

In the last two months, forecasts for profits at GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have increased from 114p per share to 116p. Combined with the recent share price falls, the stock now looks a combined value-income play.

From the current forecasts, GlaxoSmithKline is on a 2013 price-to-earnings (P/E) ratio of 13.6, falling to 12.3 times the 2014 estimate. Dividends for the year are forecast to hit 77.7p per share, equal to a 4.9% yield at today’s share price. The payout is expected to increase further for 2014, rising to 81.7p — a 5.2% yield.

With the shares down 9% in the last month, Glaxo looks a great opportunity to pick up a blue-chip share with a well-covered high yield.

Schroders

A fund management business will always be a geared play on the health of the financial markets. As equities surged in the period leading up to their May peak, analysts rushed to upgrade Schroders (LSE: SDR). In December, the City was expecting 111.6p of earnings per share (EPS) from Schroders in 2013. By May, this had reached 127.5p.

Despite the recent market setback, I still expect that the next year will see companies like Schroders experience a significant increase in demand.

However, much of that now seems to be in the price. Schroders shares are available today on 16 times 2013 forecasts, with a prospective yield of 2.5%. To justify today’s price, Schroders must meet these expectations. That leaves new buyers exposed to any future deterioration in market conditions.

Smiths Group

On the basic fundamentals, Smiths Group (LSE: SMIN) is the typical FTSE 100 share. The average forward P/E ratio for a UK blue chip is 13. Smiths trades on 13.1 times 2013 forecasts. The average expected yield from a FTSE 100 share is 3.5%. Smiths is expected to pay 3.2%.

The broad range of end markets served by Smiths has protected the business from the worst of the last five years. The oil-and-gas-facing John Crane business made a particularly strong contribution during that period. This helped ensure that the group was able to avoid losses and maintain/increase its shareholder dividend throughout.

A P/E of around 15 might be fairer, given how resilient Smiths Group has proved itself to be.

Buying quality shares at a reasonable price is one of Warren Buffett‘s best-known strategies. Mr Buffett has recently been buying shares in a different FTSE 100 company. To find out which company the world’s best investor has been stocking up on, get our free report “The One UK Share Warren Buffett Loves”. This report is totally free and will be delivered to your inbox immediately. Just click here to start reading today.

> David does not own shares in any of the above companies.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Investing Articles

Down 10% in a month with a 10% yield! Is this stock a no-brainer buy for a second income?

Harvey Jones bought this FTSE 100 stock because it offered an unmissable double-digit yield. Now he's wondering whether it will…

Read more »

Investing Articles

Here’s the latest FTSE 100 dividend forecast, and it’s growing

Despite a generally good year for UK share prices so far in 2024, yields are still strong. And the dividend…

Read more »

Dividend Shares

2 dividend shares that are smashing the rest of the FTSE 100

Jon Smith flags up two dividend shares that are well ahead of the FTSE 100 average for both the dividend…

Read more »

Investing Articles

I’d love to buy this FTSE 100 value stock today

This top-tier value stock has massively trailed the FTSE 100 so far in 2024. But as inflation holds steady and…

Read more »

Investing Articles

Down 87%, is this once-famous stock set to explode like the Rolls-Royce share price?

Unlike the roaring Rolls-Royce share price, this growth stock and former household name has totally bombed. But is it due…

Read more »

Investing Articles

As investor sentiment sinks, is the stock market about to crash?

Investor confidence has dropped sharply in recent quarters, data from Saxo Bank shows. Is a stock market crash coming? And…

Read more »

Investing Articles

If I wanted to invest in Nvidia, I’d buy this FTSE 250 stock at a 12% discount

Nvidia stock has certainly rediscovered its mojo in October. However, this investor thinks there might be a better alternative in…

Read more »

US Stock

If I’d invested £1k a year ago in the S&P 500, here’s how much more I’d have versus the FTSE 100

Jon Smith details the reasons behind the difference in performance of the S&P 500 and the FTSE 100 and outlines…

Read more »